DLBS1442 not checked
Dexa Medica Group · Dismeno 100 · Dismeno 200
FollowEvery change as it happens, and a Monday email
Trials
1 active
2 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “DLBS1442 is supplied as 100 mg oral capsules. Participants will receive either : 1. DLBS1442 100 mg + Placebo; or 2. DLBS1442 100 mg + DLBS1442 100 mg three times daily for up to 5 consecutive days during one menstrual cycle, according to the randomized treatment assignment. Treatment may be discontinued once complete pain relief is achieved (Visual Analogue Scale \[VAS\] = 0).”In the company’s words, NCT07937462 on ClinicalTrials.gov
- Tested for
- Primary Dysmenorrhea
- Main trialPhase 2/3
- “The goal of this clinical trial is to evaluate whether DLBS1442 can alleviate primary dysmenorrhea in young adults aged 18 to 21 years. The main question it aims to answer is: 1\. Does DLBS1442, at doses of 100 mg and 200 mg, reduce dysmenorrhea pain compared with placebo, as measured by the change from baseline in Visual Analogue Scale (VAS) pain score at predefined time points after the first dose? Researchers will compare DLBS1442 100 mg, DLBS1442 200 mg, with placebo to determine whether DLBS1442 is more effective in reducing dysmenorrhea pain. Participants will: 1. Take DLBS1442 or…”In the company’s words, NCT07937462 on ClinicalTrials.gov
- Other names
- Dismeno · Dismeno 100 · Dismeno 200
Other drugs for Primary Dysmenorrhea
- ElagolixAbbVie · Phase 3
- VipoglanstatGesynta Pharma AB · Phase 2
- Teverelix DPAntev Ltd. · Phase 2
Coming up1
- DecPhase 2/3 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 16 NovNew trial: none to Phase 2/3 · ClinicalTrials.gov NCT07937462
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2/3Recruiting | Dec 2026 | The Efficacy and Safety of DLBS1442 in Patients With Primary Dysmenorrhea | |
| Phase 2/3Completed | Feb 2021 | DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026